Blog
About

8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The biological cost of mutational antibiotic resistance: any practical conclusions?

      Current Opinion in Microbiology

      Virulence, drug effects, Mutation, Humans, genetics, Drug Resistance, Bacterial Physiological Phenomena, microbiology, drug therapy, Bacterial Infections, pathogenicity, metabolism, growth & development, Bacteria, therapeutic use, pharmacology, Anti-Bacterial Agents, Animals, Adaptation, Physiological

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          A key parameter influencing the rate and trajectory of the evolution of antibiotic resistance is the fitness cost of resistance. Recent studies have demonstrated that antibiotic resistance, whether caused by target alteration or by other mechanisms, generally confers a reduction in fitness expressed as reduced growth, virulence or transmission. These findings imply that resistance might be reversible, provided antibiotic use is reduced. However, several processes act to stabilize resistance, including compensatory evolution where the fitness cost is ameliorated by additional mutation without loss of resistance, the rare occurrence of cost-free resistance mechanisms and genetic linkage or co-selection between the resistance markers and other selected markers. Conceivably we can use this knowledge to rationally choose and design targets and drugs where the costs of resistance are the highest, and where the likelihood of compensation is the lowest.

          Related collections

          Author and article information

          Journal
          10.1016/j.mib.2006.07.002
          16890008

          Comments

          Comment on this article